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H u m a ns k i ns e r v e sa st h ef i r s tl i n eo fd e f e n s ea g a i n s t
pathogenic bacteria, while also providing a home to bil-
lions of symbiotic bacteria. By sequencing the DNA of
bacteria collected from the skin of humans and mouse
models of human disease, we investigated how these
bacteria contribute to health and, conversely, how
changes in the bacterial community structure might
contribute to chronic skin disorders.
Our analysis of 16S ribosomal RNA gene sequences
obtained from 20 distinct skin sites of healthy humans
revealed that physiologically comparable sites harbor
similar bacterial communities and provides a baseline
for studies that examine the role of bacterial commu-
nities in disease states and the microbial inter-depen-
dencies required to maintain healthy skin. We explored
the selective shift in the microbiota observed in skin dis-
orders commonly treated with antimicrobial agents such
as eczema and diabetic wound healing. For example, we
show that a longitudinal selective shift in wound micro-
biota coincides with impaired healing in diabetic mice.
We demonstrate a parallel shift in longitudinal gene
expression that occurs in a cluster of genes related to
the immune response. Furthermore, we establish a cor-
relation between relative abundance of Staphylococcus
spp. and the expression of cutaneous defense response
genes. These data demonstrate that integrating two
types of global data sets lends a better understanding to
the dynamics governing host-microbe interactions. Clin-
ical management of these disorders requires better bio-
markers to realize the therapeutic potential of
manipulating the microbiome. Targeted therapies to
maintain healthy skin might require not only inhibiting
t h eg r o w t ho fp a t h o g e n i cb a c teria, but also promoting
the growth of symbiotic bacteria. Microbiome studies
show the power of bridging genomics and clinical
medicine to gain valuable insight into the human body
as a complex super-organism.
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